openPR Logo
Press release

Breast Cancer Therapeutics Market Analysis with Technological Advancements, Innovative Trends, New Ideas, Strategies to 2026 and Key Players Like Pfizer, Inc., Novartis International AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, GlaxoSmithKline

01-16-2019 07:43 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Global Breast Cancer Therapeutics Market

Global Breast Cancer Therapeutics Market

Cancer is essentially the uncontrolled growth of certain cells in the body that crowd out normal cells over time. When cells in the breast begin to grow out of control it may lead to breast cancer. These cells generally form a tumor that can felt as a lump, which can further be confirmed using a mammogram. The tumor is malignant if the cells can grow into surrounding tissues or spread to other parts of the body. Breast cancer occurs almost entirely in women, though men can also contract breast cancer. Mutations in DNA can cause normal breast cells to become cancerous cells. Some DNA changes are passed on from parents and can significantly increase the threat for breast cancer. Moreover, lifestyle related risk factors such as consumption of fast food and lack of exercise can increase chances of developing breast cancer. However, the exact cause of the disease is yet unknown.

According to Breast Cancer Organization, an estimated 252,710 new cases of breast cancer are expected to be identified in the U.S., of which 63,410 cases would be non-invasive breast cancer in 2017. In the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer among women. Breast cancer is especially prevalent among women under 45 years of age and African American women rather than white women.

Download PDF Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/250

Increasing occurrence of the disease especially in the Developed countries will drive growth of the breast cancer therapeutics market

According to World Health Organization statistics, breast cancer is the second-most predominant type (whereas lung cancer is first) of the disease globally, and the most common type in females. In women, this type of cancer accounts for 20% of all invasive and 13% of all female cancers, and is responsible for 15% of deaths caused by the disease globally, including females and males. Every year, around 200,000 new cases in women and approximately 2,000 new cases are diagnosed in men. The incidence of breast cancer remained steady in white women and increased to some extent (less than 1% year) in African American women. Epidemiologists predict that the established incident cases of breast cancer in women will grow by over the following decade to reach 949,161 cases in 2025. This rise in demand will ultimately push the global breast cancer therapeutics market into a positive growth curve over the course of the forecast period.

Breast Cancer Therapeutics Market - Key Players

Key players operating in the global breast cancer therapeutics market are AstraZeneca plc, Eli Lilly and Company, Eisai Co., Ltd., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Pfizer, Inc., Novartis International AG, Puma Biotechnology, Sanofi S.A., and Teva Pharmaceutical Industries.

Breast Cancer Therapeutics Market:

On the basis of type of drug class, the global market is classified into:

• HER2 Inhibitors
• Mitotic Inhibitors
• Anti-metabolites
• Aromatase Inhibitors
• Hormone Receptor Agonist/Antagonist

Globally breast cancer is the most common cancer in women, with a prevalence of around 1.7 million in 2012, the second-most common cancer overall. This represents 12% of all new cancer cases and 25% of all cancers in women. Belgium had the topmost rate of breast cancer, followed by Denmark and France, respectively. Marginally less number of cases of breast cancer were diagnosed in less developed countries. The highest occurrence of this type of cancer was in Northern America and Oceania, whereas the lowest incidence rate in Asia and Africa.

For any Query, Talk to Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/250

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Cancer Therapeutics Market Analysis with Technological Advancements, Innovative Trends, New Ideas, Strategies to 2026 and Key Players Like Pfizer, Inc., Novartis International AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, GlaxoSmithKline here

News-ID: 1501816 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Breast

Breast Ultrasound Market Research Report and Forecast to 2028 - Conventional Bre …
A breast ultrasound is an imaging method chiefly utilized to screen for tumours and other breast abnormalities. The ultrasound use high-frequency sound waves for the production of detailed images of the inside of the breasts. The global Breast Ultrasound Market is expected to grow at a significant CAGR of 14.6% by 2028. The updated report on the Breast Ultrasound market gives a precise analysis of the value chain assessment for the review
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. Download Free PDF Brochure on Brest Imaging Market Report Now
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Automated Breast Ultrasound Systems – The Future of Breast Screening
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation. Growing awareness of breast cancer has increased number of women undergoing breast screening and in turn would propel demand for automated breast ultrasound systems (ABUS) in hospitals and diagnostic centers. ABUS enables physicians to screen women, especially with denser breasts
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can